Products & Services, Business & People, Manufacturers & Providers
EMA: New treatment for patients with soft tissue sarcoma
The European Medicines Agency (EMA) has recommended granting a conditional marketing authorisation to Lartruvo (olaratumab) for the treatment of adults with soft tissue sarcoma, a rare type of cancer.
In an unexpected move, just before the end of 2011, ...
Improving expenditure efficiency has been, for a ver...
Your Portal Link to Mass Media Universe.
Valuable Quarterly Romanian Market Analysis.
Ask the analyst
Tailor-made advice for you